_edited_edited.png)
Brooks Hill Partners has added Astrocyte Pharmaceuticals to their portfolio. This drug development company is dedicated to using the neuroprotective benefits of selective astrocyte activation to create novel therapies for brain injury patients.
Learn more about Astrocyte here.